{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:21:39Z","timestamp":1790234499189,"version":"4.1.0"},"reference-count":44,"publisher":"Impact Journals, LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,2,9]]},"DOI":"10.18632\/oncotarget.6906","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T18:07:13Z","timestamp":1452708433000},"page":"7280-7296","source":"Crossref","is-referenced-by-count":39,"title":["CXCR2 signaling regulates <i>KRAS(G12D)<\/i>-induced autocrine growth of pancreatic cancer"],"prefix":"10.18632","volume":"7","author":[{"given":"Abhilasha","family":"Purohit","sequence":"first","affiliation":[{"name":"Department of Pathology and Microbiology, 985900 Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Varney","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, 985900 Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyanarayana","family":"Rachagani","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, 985870 Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel M.","family":"Ouellette","sequence":"additional","affiliation":[{"name":"Eppley Institute, 985950 Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder K.","family":"Batra","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, 985900 Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Biochemistry and Molecular Biology, 985870 Nebraska Medical Center, Omaha, NE, USA"},{"name":"Eppley Institute, 985950 Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, 985900 Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,1,13]]},"reference":[{"key":"1","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Jemal","year":"2015","journal-title":"CA: a cancer journal for clinicians"},{"key":"2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","article-title":"Pancreatic cancer","volume":"378","author":"Goggins","year":"2011","journal-title":"Lancet"},{"key":"3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tibs.2013.12.004","article-title":"KRAS: feeding pancreatic cancer proliferation","volume":"39","author":"Der","year":"2014","journal-title":"Trends in biochemical sciences"},{"key":"4","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1158\/0008-5472.CAN-07-0175","article-title":"Dynamics of the immune reaction to pancreatic cancer from inception to invasion","volume":"67","author":"Vonderheide","year":"2007","journal-title":"Cancer research"},{"key":"5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbcan.2014.01.004","article-title":"Tumor-induced perturbations of cytokines and immune cell networks","volume":"1845","author":"Zhang","year":"2014","journal-title":"Biochimica et Biophysica Acta (BBA)-Reviews on Cancer"},{"key":"6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrclinonc.2015.105","article-title":"Inflammation and cancer: advances and new agents","volume":"12","author":"Balkwill","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cyto.2015.05.026","article-title":"Targeting of IL-4 and IL-13 receptors for cancer therapy","volume":"75","author":"Puri","year":"2015","journal-title":"Cytokine"},{"key":"8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"Yoshie","year":"2012","journal-title":"Immunity"},{"key":"9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1252","article-title":"Cytokines in cancer pathogenesis and cancer therapy","volume":"4","author":"Dranoff","year":"2004","journal-title":"Nature Reviews Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1124\/mi.8.1.6","article-title":"Oncogenic Ras\u2014Induced Expression of Cytokines in Cancer","volume":"8","author":"Counter","year":"2008","journal-title":"Molecular interventions"},{"key":"11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pharmthera.2008.10.005","article-title":"CXCR2 antagonists for the treatment of pulmonary disease","volume":"121","author":"Fine","year":"2009","journal-title":"Pharmacology & therapeutics"},{"key":"12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ccr.2013.10.009","article-title":"CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis","volume":"24","author":"DuBois","year":"2013","journal-title":"Cancer cell"},{"key":"13","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1158\/1078-0432.CCR-10-0483","article-title":"CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis","volume":"16","author":"Lin","year":"2010","journal-title":"Clinical Cancer Research"},{"key":"14","first-page":"765","article-title":"Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells","volume":"22","author":"Chayama","year":"2003","journal-title":"International journal of oncology"},{"key":"15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1159\/000151776","article-title":"Enhanced ENA-78 and IL-8 expression in patients with malignant pancreatic diseases","volume":"8","author":"Schilling","year":"2008","journal-title":"Pancreatology"},{"key":"16","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2010.11.058","article-title":"Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer","volume":"178","author":"Burdick","year":"2011","journal-title":"The American journal of pathology"},{"key":"17","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1158\/1541-7786.MCR-08-0577","article-title":"K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways","volume":"7","author":"Guha","year":"2009","journal-title":"Molecular Cancer Research"},{"key":"18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00006676-200007000-00051","article-title":"Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1","volume":"21","author":"Schraufstatter","year":"2000","journal-title":"Pancreas"},{"key":"19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1593\/tlo.13133","article-title":"CXCR2 macromolecular complex in pancreatic cancer: a potential therapeutic target in tumor growth","volume":"6","author":"Chen","year":"2013","journal-title":"Translational oncology"},{"key":"20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s002620050503","article-title":"Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells","volume":"47","author":"Watanabe","year":"1998","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"21","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.coph.2005.04.007","article-title":"Recent progress in targeting the Raf\/MEK\/ERK pathway with inhibitors in cancer drug discovery","volume":"5","author":"Lyons","year":"2005","journal-title":"Current opinion in pharmacology"},{"key":"22","doi-asserted-by":"crossref","first-page":"19125","DOI":"10.1074\/jbc.272.31.19125","article-title":"Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors Convergence of Gi-and Gq-mediated pathways on calcium\/calmodulin, Pyk2, and Src kinase","volume":"272","author":"Lefkowitz","year":"1997","journal-title":"Journal of Biological Chemistry"},{"key":"23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1349-7006.2008.00740.x","article-title":"Interleukin\u20108 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer","volume":"99","author":"Yao","year":"2008","journal-title":"Cancer science"},{"key":"24","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1038\/sj.onc.1203820","article-title":"MGSA\/GRO-mediated melanocyte transformation involves induction of Ras expression","volume":"19","author":"Richmond","year":"2000","journal-title":"Oncogene"},{"key":"25","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1093\/annonc\/mdq739","article-title":"Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer","volume":"22","author":"Lin","year":"2011","journal-title":"Annals of oncology"},{"key":"26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"Hitt","year":"2003","journal-title":"Cancer cell"},{"key":"27","doi-asserted-by":"crossref","first-page":"e80580","DOI":"10.1371\/journal.pone.0080580","article-title":"Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy","volume":"8","author":"Batra","year":"2013","journal-title":"PloS one"},{"key":"28","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1158\/1078-0432.CCR-08-2387","article-title":"Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis","volume":"15","author":"Singh","year":"2009","journal-title":"Clinical Cancer Research"},{"key":"29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nature Reviews Cancer"},{"key":"30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms","volume":"13","author":"Flavell","year":"2013","journal-title":"Nature Reviews Cancer"},{"key":"31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1172\/JCI59227","article-title":"Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice","volume":"122","author":"di Magliano","year":"2012","journal-title":"The Journal of clinical investigation"},{"key":"32","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1172\/JCI42754","article-title":"Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma","volume":"121","author":"Maeda","year":"2011","journal-title":"The Journal of clinical investigation"},{"key":"33","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/carcin\/bgp198","article-title":"ELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesis","volume":"30","author":"Counter","year":"2009","journal-title":"Carcinogenesis"},{"key":"34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ccr.2004.09.028","article-title":"Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis","volume":"6","author":"Bar-Sagi","year":"2004","journal-title":"Cancer cell"},{"key":"35","doi-asserted-by":"crossref","first-page":"16472","DOI":"10.1073\/pnas.0605752103","article-title":"The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis","volume":"103","author":"Liu","year":"2006","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"36","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1158\/0008-5472.CAN-05-3842","article-title":"High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras","volume":"66","author":"Minna","year":"2006","journal-title":"Cancer research"},{"key":"37","first-page":"627","article-title":"Induction of interleukin-8 (CXCL-8) by tumor necrosis factor-\u03b1 and leukemia inhibitory factor in pancreatic carcinoma cells: Impact of CXCL-8 as an autocrine growth factor","volume":"31","author":"Baba","year":"2007","journal-title":"International journal of oncology"},{"key":"38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/annonc\/mdq680","article-title":"Different types of K-Ras mutations could affect drug sensitivity and tumour behaviour in non-small-cell lung cancer","volume":"22","author":"Broggini","year":"2011","journal-title":"Annals of oncology"},{"key":"39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2010.10.004","article-title":"Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases","volume":"300","author":"Singh","year":"2011","journal-title":"Cancer letters"},{"key":"40","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1158\/1535-7163.MCT-11-0915","article-title":"The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models","volume":"11","author":"Venkata","year":"2012","journal-title":"Molecular cancer therapeutics"},{"key":"41","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1183\/09031936.00048509","article-title":"SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects","volume":"35","author":"Magnussen","year":"2010","journal-title":"European Respiratory Journal"},{"key":"42","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1158\/0008-5472.CAN-06-3752","article-title":"K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling","volume":"67","author":"Der","year":"2007","journal-title":"Cancer research"},{"key":"43","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/bjc.2011.31","article-title":"Activated KrasG12D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin","volume":"104","author":"Batra","year":"2011","journal-title":"British journal of cancer"},{"key":"44","first-page":"3298","article-title":"Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials","volume":"7","author":"Singh","year":"2001","journal-title":"Clinical Cancer Research"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T17:41:55Z","timestamp":1589218915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,13]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,2,9]]}},"alternative-id":["6906","26771140"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6906","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,13]]}}}